Molecular alterations underlying Doxorubicin’s Chronic Cardiotoxicity in a mouse model. RevSALUS [Internet]. 6 de Abril de 2022 [citado 15 de Maio de 2026];4(Sup):24-5. Disponível em: https://revsalus.com/index.php/RevSALUS/article/view/250